It’s hard to reconcile the sell-off in BNGO stock with Bionano’s progress in advancing the Saphyr system – but this presents an opportunity. Read More
BNGO Stock Has Disappointed, but Its NHS Deal May Turn Things Around
2021-04-30T14:12:48-04:00April 30th, 2021|
Related Posts
-
Trump classified documents trial postponed indefinitely
May 7th, 2024